`
`UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE
`Curriculum Vitae of
`THOMAS A. ALBINI, M.D.
`
`DATE:
`
`
`
`
`
`
`
`May 2, 2021
`
`
`
`
`1.
`
`I.
`
`2.
`
`3.
`
`3.
`
`4.
`
`
`
`
`
`
`
`
`5.
`
`
`6.
`
`
`
`7.
`
`8.
`
`9.
`
`10. Visa Type:
`
`
`PERSONAL
`
`Name:
`
`Home Phone:
`
`Mobile Phone:
`
`Office Address:
`
`
`
`
`Office Phone:
`Office Facsimile:
`Office E-mail:
`
`Home Address:
`
`Current Academic Rank:
`
`Thomas Arno Albini
`
`(786) 452-7120
`
`(305) 742-3578
`
`Bascom Palmer Eye Institute
`University of Miami
`Miller School of Medicine
`900 NW 17th Street, Suite #264
`Miami, FL 33136
`(305) 482-5006
`(305) 326-6417
`talbini@med.miami.edu
`
`3860 Battersea Road
`Miami, FL 33133
`
`Professor
`
`Current Appointment Track: Clinical Educator track
`
`Primary Department:
`
`Secondary Appointment:
`
`Citizenship:
`
`Ophthalmology
`
`None
`
`United States of America
`
`Not applicable
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 1
`
`Joining Petitioner: Apotex
`
`

`

`HIGHER EDUCATION
`
`Institutional:
`
`
`
`
`
`
`
`
`
`
`Magna Cum Laude. Princeton University. A.B., June 1990 – July 1994
`Princeton, New Jersey.
`
`
`
`Johns Hopkins University School of Medicine, M.D., July 1994 – May
`1999, Baltimore, Maryland.
`
`Jackson Memorial Hospital, Internal Medicine, Internship, June 1999 –
`June 2000, Miami, Florida
`
`
`
`
`
`
`
`
`
`
`
`University of Southern California, Ophthalmology Residency, July 2000 –
`July 2003, Los Angeles, California
`
`
`University of Southern California, Department of Ophthalmology, Uveitis
`and Ocular Pathology Fellowship, July 2003 – July 2004, Los Angeles,
`California
`
`Baylor College of Medicine, Department of Ophthalmology, Vitreoretinal
`Surgery Fellowship, July 2004 – July 2006, Houston, Texas
`
`II.
`
`11.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`12. Non-Institutional: Not applicable
`
`
`13. Certification and Licensure:
`
`
`American Board of Ophthalmology
`State of Florida, ME95348
`
`FL DEA, BA8331605
`
`
`
`EXPERIENCE
`
`
`
`
`
`10/2006 – 12/31/2026
`3/2/2006 to1/31/2022
`6/02/2009 to 6/30/2021
`
`III.
`
`14. Academic:
`
`
`
`
`
`
`
`
`
`
`Professor of Clinical Ophthalmology,
`Bascom Palmer Eye Institute, University of Miami Miller School of
`Medicine, Department of Ophthalmology, Miami, FL, 2018-present
`
`Associate Professor of Clinical Ophthalmology,
`Bascom Palmer Eye Institute, University of Miami Miller School of
`Medicine, Department of Ophthalmology, Miami, FL, 2012 – 2018
`
`Assistant Professor of Clinical Ophthalmology,
`Bascom Palmer Eye Institute, University of Miami Miller School of
`Medicine, Department of Ophthalmology, Miami, FL, 2006 – 2012
`
`Instructor in Ocular Inflammation, Uveitis, and Ophthalmic pathology,
`
`Page 2 of 50
`
`
`
`
`
`
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 2
`
`Joining Petitioner: Apotex
`
`

`

`Doheny Eye Institute, Keck School of Medicine, University of Southern
`California, Los Angeles, CA, July 2003 – 2004.
`
`Staff Ophthalmologist, Anne Bates Leach Eye Hospital, Bascom
`Palmer Eye Institute, University of Miami Miller School of Medicine,
`Department of Ophthalmology, Miami, FL, 2006-present.
`
`
`
`
`15. Hospital Appointments:
`
`
`
`
`
`
`Staff Ophthalmologist, Jackson Memorial Hospital, University of Miami Miller
`School of Medicine, Department of Ophthalmology, Miami, FL, 2006 – 2019.
`
`
`16. Non-Academic: Not applicable
`
`
`17. Military: Not applicable
`
`
`IV.
`
`18. Books and Monographs Published:
`
`
`PUBLICATIONS
`
`1. Lakhanpal R, Albini TA, Holz E. “Fungal Endophthalmitis”, Current Ocular
`Therapy, 6th Edition. Ed. F. Hampton Roy, Frederick T. Fraunfelder & Frederick
`W. Fraunfelder, Published by Saunders Elsevier, 2007, Chapter 257, pp. 474-
`478.
`
`2. Albini TA, Rao N. “Immunological Processes in Ocular Disease”, Pathobiology
`of Ocular Disease. 3rd Edition. Ed. Gordon Klintworth. Published by Informa
`Healthcare, 2008, Chapter 3, pp. 47-68.
`
`3. Albini TA, Davis JL. “Ocular Immunity and Inflammation”, Retinal
`Pharmacotherapy. Ed: Quan Dong Nguyen, Eduardo Büchele Rodrigues, Michel
`Eid Farah, William F. Mieler, Published by Saunders Elsevier, 2010, Chapter 5,
`pp. 37-43.
`
`
`4. Albini TA. “How Do I work-Up a Patient with Intermediate Uveitis or Panuveitis.”
`Curbside Consultation in Retina: 49 Clinical Questions. Ed: Sharon Fekrat, MD,
`Published by Slack Incorporated, 2010, Question 48, pp. 197-200.
`
`
`5. Davis JL and Albini TA. “Biopsy Analysis” Surgical Management of Intraocular
`Inflammation and Infection. Eliott D and Rao PK, eds. Published by JP Medical
`Publishers, 2013, Chapter 16, pp. 109-120.
`
`
`6. Thomas BJ and Albini TA. “Serous Detachments of the Neural Retina”.
`Ophthalmology, 4th Edition. Yanoff M and Duker JS, eds. Published by Elsevier,
`2014, Chapter 6.39, pp. 653-659.
`
`
`
`Page 3 of 50
`
`
`
`
`
`
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 3
`
`Joining Petitioner: Apotex
`
`

`

`7. Albini TA, Schwartz SG & Davis JL. “Vitrectomy”. Intraocular Inflammation.
`Zierhut M, Pavesio C, Ohno S, Orefice F, Rao NA, eds. Published by Springer,
`2016, Chapter 39. pp. 493-499.
`
`
`8. Rehlan N, Flynn HW, and Albini TA. “Exudative Retinal Detachment”. Manual of
`Retinal Disease. Medina CA, Townsend JH and Singh AD, eds. Published by
`Springer, 2016, Chapter 53, pp. 263-268.
`
`
`9. Cabrera M, Rehlan N, and Albini TA. “Noninfectious Chorioretinal Inflammatory
`Conditions” Vitreoretinal Disease: The Essentials 2nd Edition. Drs. Ingrid U. Scott,
`Carl D. Regillo, Harry W. Flynn, Jr., and Gary C. Brown, eds. Thieme Medical
`Publishers, 2018. Chapter 25, pp. 404-427.
`
`
`10. Kodati S, Burke SP, and Albini TA. “Indocyanine Green Angiography in Uveitis”
`Multimodal Imaging in Uveitis. Sen HN and Read RW, eds. Springer, 2017.
`Chapter 2.
`
`
`11. Arriola AE, Fortun JA, Albini TA. “Toxoplasmosis ocular” Manual De Retina
`Medica Y Quirurgica. Juarez SR and Sanchez Ramos JA eds. Wolters Kluwer.
`2018. Chapter 58.
`
`
`12. Arriola AE, Fortun JA, Albini TA. “Toxocariasis ocular” Manual De Retina Medica
`Y Quirurgica. Juarez SR and Sanchez Ramos JA eds. Wolters Kluwer. 2018.
`Chapter 59.
`
`
`13. Arriola AE, Fortun JA, Albini TA. “Sindrome presunto de histoplasmosis ocular”
`Manual De Retina Medica Y Quirurgica. Juarez SR and Sanchez Ramos JA eds.
`Wolters Kluwer. 2018. Chapter 60.
`
`
`14. Arriola AE, Fortun JA, Albini TA. “Sindrome presunto de histoplasmosis ocular”
`Manual De Retina Medica Y Quirurgica. Juarez SR and Sanchez Ramos JA eds.
`Wolters Kluwer. 2018. Chapter 60.
`
`
`15. Arriola AE, Fortun JA, Albini TA. “Retinitis por citomegalovirus” Manual De
`Retina Medica Y Quirurgica. Juarez SR and Sanchez Ramos JA eds. Wolters
`Kluwer. 2018. Chapter 61.
`
`
`16. Arriola AE, Fortun JA, Albini TA. “Necrosis retiniana externa progresiva” Manual
`De Retina Medica Y Quirurgica. Juarez SR and Sanchez Ramos JA eds. Wolters
`Kluwer. 2018. Chapter 62.
`
`
`17. Arriola AE, Fortun JA, Albini TA. “Necrois retiniana aguda” Manual De Retina
`Medica Y Quirurgica. Juarez SR and Sanchez Ramos JA eds. Wolters Kluwer.
`2018. Chapter 63.
`
`
`18. Yannuzzi N.A., Fisher Y., Albini T. (2020) The Role of Endoscopy in Uveitic
`Eyes. In: Pichi F., Neri P. (eds) Complications in Uveitis. Springer, Cham.
`
`
`
`
`
`Page 4 of 50
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 4
`
`Joining Petitioner: Apotex
`
`

`

`19. Hussain R.M., Albini T.A., Flynn H.W. (2020) Retinal and Choroidal Biopsies. In:
`Pichi F., Neri P. (eds) Complications in Uveitis. Springer, Cham.
`
`
`
`19.
`
`
`Juried or Refereed Papers:
`
`1. Noori J, Shi Y, Yang J, Gregori G, Albini TA, Rosenfeld PJ, Davis JL. A Novel
`Method to Detect and Monitor Retinal Vasculitis Using Swept-Source OCT
`Angiography. Ophthalmol Retina. 2021 Feb 19:S2468-6530(21)00057-9. doi:
`
`2. Patel NA, Fan KC, Yannuzzi NA, Fortun JA, Haddock LJ, Yoo SH, Persad PJ,
`Vanner EA, Read SP, Williams BK, Sridhar J, Albini TA, Flynn HW, Donaldson K,
`Townsend JH. Refractive Outcomes of Four-Point Scleral Fixation of Akreos
`AO60 Intraocular Lens Using Gore-Tex Suture. Clin Ophthalmol. 2020 Dec
`21;14:4431-4437. doi: 10.2147/OPTH.S282094.
`
`3. Monés J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, Holz FG,
`Korobelnik JF, Kim IK, Pruente C, Murray TG, Heier JS. Risk of Inflammation,
`Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post
`Hoc Review of HAWK and HARRIER. Ophthalmology. 2020 Nov 15:S0161-
`6420(20)31075-7.
`
`4. Echegaray JJ, Vanner EA, Zhang L, Fortun JA, Albini TA, Berrocal AM, Smiddy
`WE, Flynn HW Jr, Sridhar J, Gregori NZ, Townsend JH, Davis JL, Haddock LJ.
`Outcomes of Pars Plana Vitrectomy Alone versus Combined Scleral Buckling
`plus Pars Plana Vitrectomy for Primary Retinal Detachment. Ophthalmol Retina.
`2021 Feb;5(2):169-175. doi: 10.1016/j.oret.2020.09.013. Epub 2020 Sep 25.
`
`5. Li AL, Palejwala NV, Shantha JG, O'Keefe G, Lee CS, Albini T, Yeh S. Long-term
`multimodal imaging in acute posterior multifocal placoid pigment epitheliopathy
`and association with coxsackievirus exposure. PLoS One. 2020 Aug
`24;15(8):e0238080.
`
`6. Baumal CR, Spaide RF, Vajzovic L, Freund KB, Walter SD, John V, Rich R,
`Chaudhry N, Lakhanpal RR, Oellers PR, Leveque TK, Rutledge BK, Chittum M,
`Bacci T, Enriquez AB, Sund NJ, Subong ENP, Albini TA. Retinal Vasculitis and
`Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
`Ophthalmology. 2020 Oct;127(10):1345-1359
`
`7. Russell JF, Albini TA, Berrocal AM, Dubovy SR, Rosenfeld PJ, Smiddy WE,
`Sridhar J, Townsend JH, Flynn HW Jr. Anti-Vascular Endothelial Growth Factor
`Therapy for Choroidal Rupture-Associated Choroidal Neovascularization.
`Ophthalmol Retina. 2020 Feb;4(2):226-228.
`
`8. Brown K, Yannuzzi NA, Callaway NF, Patel NA, Relhan N, Albini TA, Berrocal
`AM, Davis JL, Fortun JA, Smiddy WE, Sridhar J, Flynn HW Jr, Townsend JH.
`Surgical Outcomes Of Rhegmatogenous Retinal Detachment In Young Adults
`Ages 18-30 Years. Clin Ophthalmol. 2019 Oct 31;13:2135-2141.
`
`
`
`Page 5 of 50
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 5
`
`Joining Petitioner: Apotex
`
`

`

`
`9. Yannuzzi NA, Smith L, Yadegari D, Venincasa MJ, Al-Khersan H, Patel NA,
`Albini T, Berrocal AM, Flynn HW Jr, Sridhar J. ANALYSIS OF THE
`VITREORETINAL SURGICAL FELLOWSHIP APPLICANT POOL: Publication
`Misrepresentations and Predictors of Future Academic Output. Retina. 2020
`Oct;40(10):2026-2033.
`
`10. Stiefel HC, Kopplin LJ, Albini T, Chang M, Vegunta S, Suhler EB. Treatment of
`Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A
`Retrospective Chart Review. Ocul Immunol Inflamm. 2019 Nov 19:1-6.
`
`11. Bae JH, Al-Khersan H, Yannuzzi NA, Hasanreisoglu M, Androudi S, Albini TA,
`Nguyen QD. Surgical Therapy for Macular Edema: What We Have Learned
`through the Decades. Ocul Immunol Inflamm. 2019;27(8):1242-1250.
`
`12. Albini TA, Rice JB, White AG, Johnson M, Reiff J, Lima AF, Bartels-Peculis L,
`Ciepielewska G, Nelson WW. Economic Burden of Non-Infectious Inflammatory
`Eye Disease (NIIED) in a Commercially-Insured Population in the United States.
`Ocul Immunol Inflamm. 2020;28(1):164-174.. Epub 2019 Feb 22. PubMed PMID:
`30794006.
`
`
`13. Russell JF, Albini TA, Berrocal AM, Dubovy SR, Rosenfeld PJ, Smiddy WE,
`Sridhar J, Townsend JH, Flynn HW Jr. Anti-Vascular Endothelial Growth Factor
`Therapy for Choroidal Rupture-Associated Choroidal Neovascularization.
`Ophthalmol Retina. 2020 Feb;4(2):226-228. PubMed PMID: 32033715.
`
`
`14. Brown K, Yannuzzi NA, Callaway NF, Patel NA, Relhan N, Albini TA, Berrocal
`AM, Davis JL, Fortun JA, Smiddy WE, Sridhar J, Flynn HW Jr, Townsend JH.
`Surgical Outcomes Of Rhegmatogenous Retinal Detachment In Young Adults
`Ages 18-30 Years. Clin Ophthalmol. 2019 Oct 31;13:2135-2141. PubMed PMID:
`31802843; PubMed Central PMCID: PMC6827499.
`
`
`15. Yannuzzi NA, Smith L, Yadegari D, Venicasa MJ, Al-Khersan H, Patel NA, Albini
`T, Berrocal AM, Flynn HW Jr, Sridhar J. ANALYSIS OF THE VITREORETINAL
`SURGICAL FELLOWSHIP APPLICANT POOL: Publication Misrepresentations
`and Predictors of Future Academic Output. Retina. 2019 Nov 21. PubMed PMID:
`31764610.
`
`
`16. Stiefel HC, Kopplin LJ, Albini T, Chang M, Vegunta S, Suhler EB. Treatment of
`Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A
`Retrospective Chart Review. Ocul Immunol Inflamm. 2019 Nov 19:1-6. PubMed
`PMID: 31743052.
`
`
`17. Nelson WW, Rice JB, White AG, Johnson M, Reiff J, Lima AF, Bartels-Peculis L,
`Ciepielewska G, Albini TA. Predictors of High-cost Patients With
`NoninfectiousInflammatory Eye Diseases. Clin Ther. 2019 Nov;41(11):2331-
`2342. PubMed PMID: 31607561.
`
`
`
`
`
`Page 6 of 50
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 6
`
`Joining Petitioner: Apotex
`
`

`

`18. Yannuzzi NA, Sridhar J, Flynn HW Jr, Gayer S, Berrocal AM, Patel NA,
`Townsend J, Smiddy WE, Albini T. Current Trends in Vitreoretinal Anesthesia.
`Ophthalmol Retina. 2019 Sep;3(9):804-805. May 29.PubMed PMID: 31307941.
`
`
`19. Venincasa MJ, Hubschman S, Kuriyan AE, Berrocal A, Sivalingam A, Albini TA,
`Sridhar J. Perceptions of Vitreoretinal Surgical Fellowship Training in the United
`States. Ophthalmol Retina. 2019 Sep;3(9):802-804. Epub 2019 May 10. PubMed
`PMID: 31253472.
`
`
`20. Yannuzzi NA, Patel NA, Relhan N, Tran KD, Si N, Albini TA, Berrocal AM, Davis
`JL, Smiddy WE, Townsend J, Miller D, Flynn HW Jr. Clinical Features, Antibiotic
`Susceptibilities, and Treatment Outcomes of Endophthalmitis Caused by
`Staphylococcus epidermidis. Ophthalmol Retina. 2018 May;2(5):396-400. Epub
`2017 Nov 2. PubMed PMID: 31047321.
`
`
`21. Nirwan RS, Albini TA, Sridhar J, Flynn HW Jr, Kuriyan AE. Assessing "Cell
`Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-
`Consumer Marketing Websites in the United States. Ophthalmology. 2019
`Oct;126(10):1350-1355.. Epub 2019 Mar 21. PubMed PMID: 30904542; PubMed
`Central PMCID: PMC6754792.
`
`
`22. Albini TA, Rice JB, White AG, Johnson M, Reiff J, Lima AF, Bartels-Peculis L,
`Ciepielewska G, Nelson WW. Economic Burden of Non-Infectious Inflammatory
`Eye Disease (NIIED) in a Commercially-Insured Population in the United States.
`Ocul Immunol Inflamm. 2020;28(1):164-174. Epub 2019 Feb 22. PubMed PMID:
`30794006.
`
`
`23. Hussain RM, Dubovy SR, Kuriyan AE, Zhou XY, Flynn HW Jr, Albini TA.
`Clinicopathologic Correlations of Retinal Membranes Associated With Intravitreal
`'Stem Cell' Injections. Ophthalmic Surg Lasers Imaging Retina. 2019 Feb
`1;50(2):125-131. doi: 10.3928/23258160-20190129-11. PubMed PMID:
`30768222.
`
`24. Patel NA, Shah P, Yannuzzi NA, Ansari Z, Zaveri JS, Relhan N, Williams BK Jr,
`Kuriyan AE, Henry CR, Sridhar J, Haddock L, Fortun JA, Albini TA, Davis JL,
`Flynn HW Jr. Clinical outcomes of 4-point scleral fixated 1-piece hydrophobic
`acrylic equiconvex intraocular lens using polytetrafluoroethylene suture. Clin
`Ophthalmol. 2018 Oct 23;12:2145-2148. doi: 10.2147/OPTH.S174211.
`eCollection 2018. PubMed PMID: 30425449; PubMed Central PMCID:
`PMC6205144.
`
`25. Rodriguez M, Lin J, Townsend JH, Smiddy WE, Albini TA, Berrocal AM, Sridhar
`J, Flynn HW Jr. Giant retinal tears: clinical features and outcomes of vitreoretinal
`surgery at a university teaching hospital (2011-2017). Clin Ophthalmol. 2018 Oct
`12;12:2053-2058. doi: 10.2147/OPTH.S180353. eCollection 2018. PubMed
`PMID: 30349189; PubMed Central PMCID: PMC6190638.
`
`
`
`
`Page 7 of 50
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 7
`
`Joining Petitioner: Apotex
`
`

`

`26. Callaway NF, Gonzalez MA, Yonekawa Y, Faia LJ, Mandelcorn ED, Khurana
`RN, Saleh MGA, Lin P, Sobrin L, Albini TA. OUTCOMES OF PARS PLANA
`VITRECTOMY FOR MACULAR HOLE IN PATIENTS WITH UVEITIS. Retina.
`2018 Sep;38 Suppl 1:S41-S48. doi: 10.1097/IAE.0000000000001942. PubMed
`PMID: 29117067; PubMed Central PMCID: PMC5938143.
`
`27. Ahmad S, Lopez M, Attala M, Galor A, Stanciu NA, Miller D, Suh L, Albini T,
`Perez VL, Karp CL, Davis JL, Alfonso E, Forster RK, Amescua G. Interventions
`and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year
`Perspective. Ocul Immunol Inflamm. 2017 Oct 17:1-8. doi:
`10.1080/09273948.2017.1372484. [Epub ahead of print] PubMed PMID:
`29040032; PubMed Central PMCID: PMC6240493.
`
`28. Kuriyan AE, Sridhar J, Flynn HW Jr, Huang LC, Yannuzzi NA, Smiddy WE, Davis
`JL, Albini TA, Berrocal AM, Miller D. Endophthalmitis Caused by
`Corynebacterium Species: Clinical Features, Antibiotic Susceptibility, and
`Treatment Outcomes. Ophthalmol Retina. 2017 May-Jun;1(3):200-205. doi:
`10.1016/j.oret.2016.11.007. PubMed PMID: 28971164; PubMed Central PMCID:
`PMC5621745.
`
`29. Banker TP, McClellan AJ, Wilson BD, Juan FM, Kuriyan AE, Relhan N, Chen FV,
`Weichel ED, Albini TA, Berrocal AM, Sridhar J, Gregori NZ, Townsend JH, Flynn
`HW Jr. Culture-Positive Endophthalmitis After Open Globe Injuries With and
`Without Retained Intraocular Foreign Bodies. Ophthalmic Surg Lasers Imaging
`Retina. 2017 Aug 1;48(8):632-637. doi: 10.3928/23258160-20170802-05.
`PubMed PMID: 28810038.
`
`30. Albini T, Callaway NF, Pershing S, Wang SK, Moshfeghi AA, Moshfeghi DM.
`Trends in Hospitalization and Incidence Rate for Syphilitic Uveitis in the United
`States From 1998 to 2009. Am J Ophthalmol. 2017 Aug;180:133-141. doi:
`10.1016/j.ajo.2017.05.013. Epub 2017 May 24. PubMed PMID: 28549847.
`
`31. Perez VL, Leung EH, Berrocal AM, Albini TA, Parel JM, Amescua G, Alfonso EC,
`Ali TK, Gibbons A. Impact of Total Pars Plana Vitrectomy on Postoperative
`Complications in Aphakic, Snap-On, Type 1 Boston Keratoprosthesis.
`Ophthalmology. 2017 Oct;124(10):1504-1509. doi:
`10.1016/j.ophtha.2017.04.016. Epub 2017 May 17. PubMed PMID: 28528012.
`
`32. Pichi F, Sarraf D, Arepalli S, Lowder CY, Cunningham ET Jr, Neri P, Albini
`TA, Gupta V, Baynes K, Srivastava SK. The application of optical coherence
`tomography angiography in uveitis and inflammatory eye diseases. Prog Retin
`Eye Res. 2017 Jul;59:178-201. doi: 10.1016/j.preteyeres.2017.04.005. Epub
`2017 Apr 29. Review. PubMed PMID: 28465249.
`
`33. Kuriyan AE, Albini TA, Townsend JH, Rodriguez M, Pandya HK, Leonard RE
`2nd, Parrott MB, Rosenfeld PJ, Flynn HW Jr, Goldberg JL. Vision Loss after
`Intravitreal Injection of Autologous “Stem Cells” for AMD. N Engl J Med. 2017
`
`
`
`Page 8 of 50
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 8
`
`Joining Petitioner: Apotex
`
`

`

`Mar 16;376(11):1047-1053. doi:10.1056/NEJMoa1609583. PubMed PMID:
`27296617.
`
`34. Yannuzzi NA, Si N, Relhan N, Kuriyan AE, Albini TA, Berrocal AM, Davis JL,
`Smiddy WE, Townsend J, Miller D, Flynn HW Jr. Endophthalmitis After Clear
`Corneal Cataract Surgery: Outcomes Over Two Decades. Am J Ophthalmol.
`2017 Feb; 174:155-159. doi: 10.1016/j.ajo.2016.11.006. PubMed PMID:
`27889501.
`
`35. Ho AC, Albini TA, Brown DM, Boyer DS, Regillo CD, Heier JS. The Potential
`Importance of Detection of Neovascular Age-Related Macular Degeneration
`When Visual Acuity is Relatively Good. JAMA Ophthalmol. 2017 Jan 19; PubMed
`PMID: 28114653.
`
`36. Pichi F, Srvivastava SK, Chexal S, Lembo A, Lima LH, Neri P, Saitta A,
`Chhablani J, Albini TA, Nucci P, Freund KB, Chung H, Lowder CY, Sarraf D.
`En Face Optical Coherence Tomography and Optical Coherence Tomography
`Angiography of Multiple Evanescent White Dot Syndrome: New Insights into
`Pathogenesis. Retina 2016 Dec;36 Suppl 1;S178-S188. PubMed PMID:
`28005676.
`
`37. Ventura CV, Albini TA, Berrocal AM. First Locally Transmitted Zika Virus Cases
`Identified in the United States. JAMA Ophthalmol. 2016 Nov 1;134(11):1219-
`1220. PubMed PMID: 27685812.
`
`38. Gayer S, Palte HD, Albini TA, Flynn HW Jr, Martinez-Ruiz R, Salas N, McClellan
`AJ, Relhan N, Parel JM. In Vivo Porcine Model of Venous Air Embolism During
`Pars Plana Vitrectomy. Am J Ophthalmol. 2016 Nov;171:139-144. PubMed
`PMID: 27349413.
`
`39. Burke S, Albini TA, Silgado JD, Williams BK, Parel JM. Fluocinolone Implant
`Forceps: Instrument Modification for Enhanced Implant Insertion. Int Ophthalmol
`Clin. 2016 Fall;56(4):113-8. PubMed PMID: 27575762; NIHMSID:
`NIHMS795491; PubMed Central PMCID: PMC5006688.
`
`40. Pichi F, Srvivastava SK, Chexal S, Lembo A, Lima LH, Neri P, Saitta A,
`Chhablani J, Albini TA, Nucci P, Freund KB, Chung H, Lowder CY, Sarraf D. En
`Face Optical Coherence Tomography and Optical Coherence Tomography
`Angiography of Multiple Evanescent White Dot Syndrome. New Insights into
`Pathogenesis. Retina. 2016 Aug 22; PubMed PMID: 27552295.
`
`41. Shah M, Relhan N, Kuriyan AE, Davis JL, Albini TA, Pathengay A, Miller D,
`Flynn HW Jr. Endophthalmitis Caused by Nontuberculous Mycobacterium:
`Clinical Features, Antimicrobial Susceptibilities, and Treatment Outcomes. Am J
`Ophthalmol. 2016 Aug;168;150-6. PubMed PMID: 27048999.
`
`42. Medina CA, Butler MR, Deobhakta AA, Banitt MR, Albini TA, Smiddy WE,
`Berrocal AM, Gedde SJ, Flynn HW Jr. Endophthalmitis Associated with
`
`
`
`Page 9 of 50
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 9
`
`Joining Petitioner: Apotex
`
`

`

`Glaucoma Drainage Implants. Ophthalmic Surg Lasers Imaging Retina. 2016 Jun
`1;47(6):563-9. PubMed PMID: 27327286.
`
`43. Relhan N, Albini TA, Pathengay A, Kuriyan AE, Miller D, Flynn HW.
`Endophthalmitis caused by Gram-positive organisms with reduced vancomycin
`susceptibility: literature review and options for treatment. Br J Ophthalmol.
`2016 Apr;100(4):446-52. doi: 10.1136/bjophthalmol-2015-307722. Epub 2015
`Dec 23. Review. PubMed PMID: 26701686.
`
`44. Marsiglia M, Gallego-Pinazo R, Cunha de Souza E, Munk MR, Yu S, Mrejen S,
`Cunningham ET Jr, Lujan BJ, Goldberg NR, Albini TA, Gaudric A, Francais C,
`Rosen RB, Freund KB, Jampol LM, Yannuzzi LA. Expanded Clinical Spectrum of
`Multiple Evanescent White Dot Syndrome with Multimodal Imaging. Retina. 2016
`Jan;36(1):64-74. doi: 10.1097/IAE.0000000000000685. PubMed PMID:
`26166804.
`
`45. Albini TA, Davis JL. Ocular Immunity and Inflammation. Dev Ophthalmol.
`2016;55:38-45. doi: 10.1159/000431131. Epub 2015 Oct 26. Review. PubMed
`PMID: 26501148.
`
`46. Henry CR, Sisk RA, Tzu JH, Albini TA, Davis JL, Murray TG, Berrocal AM.
`Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric
`retinal and choroidal diseases. J AAPOS. 2015 Dec;19(6):541-8. doi:
`10.1016/j.jaapos.2015.09.006. PubMed PMID: 26691034.
`
`47. Witkin AJ, Shah AR, Engstrom RE, Kron-Gray MM, Baumal CR, Johnson MW,
`Witkin DI, Leung J, Albini TA, Moshfeghi AA, Batlle IR, Sobrin L, Eliott D.
`Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical
`Spectrum and Possible Association with Vancomycin. Ophthalmology. 2015
`Jul;1227):1438-51. PubMed PMID: 25886796.
`
`48. Reddy AK, Gonzalez MA, Henry CR, Yeh S, Sobrin L, Albini TA. Diagnostic
`Sensitivity of Indocyanine Green Angiography for Birdshot Chorioretinopathy.
`JAMA Ophthalmol. 2015 Jul;133(7):840-3.
`doi:10.1001/jamaophthalmol.2015.0822. PubMed PMID: 25906054.
`
`49. Shantha JG, Weissman HM, Debiec MR, Albini TA, Yeh S. Advances in the
`management of acute retinal necrosis. Int Ophthalmol Clin. 2015
`Summer;55(3):1-13. doi: 10.1097/IIO.0000000000000077. Review. PubMed
`PMID: 26035758; PubMed Central PMCID: PMC4567584.
`
`50. Relhan N, Yeh S, Albini TA. Intraocular Sustained-release Steroids for
`Uveitis. Int Ophthalmol Clin. 2015 Summer;55(3):25-38. doi:
`10.1097/IIO.0000000000000075. Review. PubMed PMID: 26035760.
`
`51. Gregori NZ, Flynn HW Jr, Schwartz SG, Rosenfeld PJ, Vaziri K, Moshfeghi AA,
`Fortun JA, Kovach JL, Dubovy SR, Albini TA, Davis JL, Berrocal AM, Smiddy
`WE. Current Infectious Endophthalmitis Rates After Intravitreal Injections of
`
`Page 10 of 50
`
`
`
`
`
`
`
`
`
`
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 10
`
`Joining Petitioner: Apotex
`
`

`

`Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.
`Ophthalmic Surg Lasers Imaging Retina. 2015 Jun;46(6):643-8. doi:
`10.3928/23258160-20150610-08. PubMed PMID: 26114845.
`
`52. Parekh A, Srivastava S, Bena J, Albini T, Nguyen QD, Goldstein DA. Risk
`factors associated with intraocular pressure increase in patients with uveitis
`treated with the fluocinolone acetonide implant. JAMA Ophthalmol. 2015
`May;133(5):568-73. doi: 10.1001/jamaophthalmol.2015.51. PubMed PMID:
`25719937.
`
`53. Mandelcorn ED, Manusow JS, Parke DW 3rd, Albini TA. Unassisted Scleral
`Depression During Vitrectomy Surgery: Two Simple, Cost-Effective Techniques.
`Ophthalmic Surg Lasers Imaging Retina. 2015 May;46(5):577-8. doi:
`10.3928/23258160-20150521-10. PubMed PMID: 26057762.
`
`54. Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk factors
`predictive of endogenous endophthalmitis among hospitalized patients with
`hematogenous infections in the United States. Am J Ophthalmol. 2015
`Mar;159(3):498-504. doi: 10.1016/j.ajo.2014.11.032. Epub 2014 Dec 6. PubMed
`PMID: 25486541.
`
`55. Chao DL, Marsiglia M, Ahmad B, Sridhar J, Shah GK, de Souza EC, Yannuzzi
`LA, Albini TA. Peripapillary serous detachment in multiple evanescent white dot
`syndrome. Retina. 2015 Mar;35(3):521-4. doi: 10.1097/IAE.0000000000000372.
`PubMed PMID: 25545483.
`
`56. Cunningham ET Jr, Rathinam SR, Albini TA, Chee SP, Zierhut M. Tuberculous
`uveitis. Ocul Immunol Inflamm. 2015 Feb;23(1):2-6. doi:
`10.3109/09273948.2014.1004016. Review. PubMed PMID: 25615806.
`
`57. Choudhury H, Jindal A, Pathengay A, Bawdekar A, Albini T, Flynn HW Jr. The
`role of intravitreal trimethoprim/sulfamethoxazole in the treatment of toxoplasma
`retinochoroiditis. Ophthalmic Surg Lasers Imaging Retina. 2015 Jan;46(1):137-
`40. doi: 10.3928/23258160-20150101-27. PubMed PMID: 25559528.
`
`58. Carvounis PE, Albini TA, Barkmeier AJ, Tsilimbaris M. Advances in retinal
`therapeutics. J Ophthalmol. 2015;2015:515193. doi: 10.1155/2015/515193. Epub
`2015 Mar 9. PubMed PMID: 25838940; PubMed Central PMCID: PMC4369938.
`
`59. Cunningham ET Jr, de Smet MD, Yeh S, Albini TA, Zierhut M. Sustained-
`release Corticosteroids for Uveitis. Ocul Immunol Inflamm. 2015;23(6):421-4. doi:
`10.3109/09273948.2015.1114778. PubMed PMID: 26652837.
`
`60. Reddy AK, Cabrera M, Yeh S, Davis JL, Albini TA. Optical coherence
`tomography-guided ranibizumab injection for cystoid macular edema in
`well-controlled uveitis: twelve-month outcomes. Retina. 2014 Dec;34(12):2431-8.
`doi: 10.1097/IAE.0000000000000274. PubMed PMID: 25170857.
`
`
`Page 11 of 50
`
`
`
`
`
`
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 11
`
`Joining Petitioner: Apotex
`
`

`

`61. Kuriyan AE, Sridhar J, Flynn HW Jr, Smiddy WE, Albini TA, Berrocal AM,
`Forster RK, Belin PJ, Miller D. Endophthalmitis caused by Enterococcus faecalis:
`clinical features, antibiotic sensitivities, and outcomes. Am J Ophthalmol. 2014
`Nov;158(5):1018-23. doi: 10.1016/j.ajo.2014.07.038. Epub 2014 Aug 1. PubMed
`PMID:25089354; PubMed Central PMCID: PMC4250282.
`
`62. Radhika M, Mithal K, Bawdekar A, Dave V, Jindal A, Relhan N, Albini T,
`Pathengay A, Flynn HW. Pharmacokinetics of intravitreal antibiotics in
`endophthalmitis. J Ophthalmic Inflamm Infect. 2014 Sep 10;4:22. doi:
`10.1186/s12348-014-0022-z. eCollection 2014. Review. PubMed PMID:
`25667683; PubMed Central PMCID: PMC4306439.
`
`63. Rachitskaya AV, Reddy AK, Miller D, Davis J, Flynn HW Jr, Smiddy W, Lara W,
`Lin S, Dubovy S, Albini TA. Prolonged Curvularia endophthalmitis due to
`organism sequestration. JAMA Ophthalmol. 2014 Sep;132(9):1123-6. doi:
`10.1001/jamaophthalmol.2014.1069. PubMed PMID: 24903581.
`
`64. Bakri SJ, Boyer DS, Albini TA, Holekamp NM, Ferrone PJ, Bhagat R, Novakovic
`Z. Comparison of the tissue penetration and glide force of 22-gauge thin-wall
`needles for intravitreal implant administration. Ophthalmic Surg Lasers Imaging.
`Retina. 2014 Sep-Oct;45(5):430-5. PubMed PMID: 25230401.
`
`65. Farias CC, Ozturk HE, Albini TA, Berrocal AM, Amescua G, Betancurt C, Parel
`JM, Oliveros MC, Gibbons A, Vargas JM, Perez VL. Use of intraocular video
`endoscopic examination in the preoperative evaluation of keratoprosthesis
`surgery to assess visual potential. Am J Ophthalmol. 2014 Jul;158(1):80-86.e2.
`doi:10.1016/j.ajo.2014.02.043. Epub 2014 Feb 26. PubMed PMID: 24582996.
`
`66. Nicholson LB, Kim BT, Jardón J, Townsend-Pico W, Santos C, Moshfeghi AA,
`Albini TA, Eliott D, Sobrin L. Severe bilateral ischemic retinal vasculitis
`following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2014
`Jul-Aug;45(4):338-42. doi: 10.3928/23258160-20140605-01. PubMed PMID:
`25127533.
`
`67. Kuriyan AE, Weiss KD, Flynn HW Jr, Smiddy WE, Berrocal AM, Albini TA, Miller
`D. Endophthalmitis caused by streptococcal species: clinical settings,
`microbiology, management, and outcomes. Am J Ophthalmol. 2014
`Apr;157(4):774-780.e1. doi: 10.1016/j.ajo.2013.12.026. Epub 2014 Jan 10.
`PubMed PMID: 24418264; PubMed Central PMCID: PMC3972252.
`
`68. Weng CY, Fortun JA, Carvounis PE, Albini TA. Ocriplasmin and its role in the
`management of vitreoretinal interface disorders. Int Ophthalmol Clin. 2014
`Spring;54(2):29-38. doi: 10.1097/IIO.0000000000000019. Review. PubMed
`PMID: 24613882.
`
`69. Shah SD, Yee KK, Fortun JA, Albini T. Optic disc pit maculopathy: a review
`and update on imaging and treatment. Int Ophthalmol Clin. 2014
`
`Page 12 of 50
`
`
`
`
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 12
`
`Joining Petitioner: Apotex
`
`

`

`Spring;54(2):61-78. doi: 10.1097/IIO.0000000000000025. Review. PubMed
`PMID: 24613885.
`
`70. Pichi F, Ciardella AP, Cunningham ET Jr, Morara M, Veronese C, Jumper JM,
`Albini TA, Sarraf D, McCannel C, Voleti V, Choudhry N, Bertelli E, Giuliari GP,
`Souied E, Amer R, Regine F, Ricci F, Neri P, Nucci P. Spectral domain optical
`coherence tomography findings in patients with acute syphilitic posterior placoid
`chorioretinopathy. Retina. 2014 Feb;34(2):373-84. PubMed PMID: 23860561.
`
`71. Cabrera M, Gonzalez A, Albini TA, Rowaan C, Aguilar M, Lee W, Fortun JA,
`Moshfeghi AA, Flynn HW Jr, Parel JM. Differential flow rate of commercially
`available triamcinolone with and without preservative through small-gauge
`needles. Ophthalmic Surg Lasers Imaging Retina. 2014 Jan-Feb;45(1):54-7. doi:
`10.3928/23258160-20131220-08. PubMed PMID: 24392913.
`
`72. Cabrera M, Yeh S, Albini TA. Sustained-release corticosteroid options. J
`Ophthalmol. 2014;2014:164692. doi: 10.1155/2014/164692. Epub 2014 Jul 23.
`Review. PubMed PMID: 25140246; PubMed Central PMCID: PMC4130028.
`
`73. Chang JS, Parke DW 3rd, Flynn HW Jr, Pathengay A, Albini T. Management of
`suprachoroidal 5,000-centistoke silicone oil: two contrasting approaches.
`Ophthalmic Surg Lasers Imaging Retina. 2013 Nov 1;44(6):610-2. doi:
`10.3928/23258160-20131022-02. Epub 2013 Oct 30. PubMed PMID: 24170121.
`
`74. Sridhar J, Flynn HW Jr, Kuriyan AE, Miller D, Albini T. Endogenous fungal
`endophthalmitis: risk factors, clinical features, and treatment outcomes in mold
`and yeast infections. J Ophthalmic Inflamm Infect. 2013 Sep 20;3(1):60. doi:
`10.1186/1869-5760-3-60. PubMed PMID: 24053550; PubMed Central PMCID:
`PMC3848556.
`
`75. Silva RA, Berrocal AM, Lam BL, Albini TA. Novel mutation in BEST1 associated
`with retinoschisis. JAMA Ophthalmol. 2013 Jun;131(6):794-8. doi:
`10.1001/jamaophthalmol.2013.2047. Erratum in: JAMA Ophthalmol. 2013
`Sep;131(9):1249. PubMed PMID: 23572118.
`
`76. Anwar Z, Galor A, Albini TA, Miller D, Perez V, Davis JL. The diagnostic
`utility of anterior chamber paracentesis with polymerase chain reaction in
`anterior uveitis. Am J Ophthalmol. 2013 May;155(5):781-6. doi:
`10.1016/j.ajo.2012.12.008. Epub 2013 Feb 12. PubMed PMID: 23415597.
`
`77. Gonzalez MA, Flynn HW Jr, Smiddy WE, Albini TA, Tenzel P. Surgery for retinal
`detachment in patients with giant retinal tear: etiologies, management
`strategies, and outcomes. Ophthalmic Surg Lasers Imaging Retina. 2013
`May-Jun;44(3):232-7. doi: 10.3928/23258160-20130503-04. PubMed PMID:
`23676223.
`
`78. Hodson KL, Galor A, Karp CL, Davis JL, Albini TA, Perez VL, Miller D, Forster
`RK. Epidemiology and visual outcomes in patients with infectious scleritis.
`
`Page 13 of 50
`
`
`
`
`
`
`
`
`
`
`
`Mylan Exhibit 1038
`Mylan v. Regeneron, IPR2021-00881
`Page 13
`
`Joining Petitioner: Apotex
`
`

`

`Cornea. 2013 Apr;32(4):466-72. doi: 10.1097/ICO.0b013e318259c952. PubMed
`PMID: 22902495.
`
`79. Gupta S, Vemulakonda GA, Suhler EB, Yeh S, Albini TA, Mandelcorn E, Flaxel
`CJ. Cytomegalovirus retinitis in the absence of AIDS. Can J Ophthalmol. 2013
`Apr;48(2):126-9. doi: 10.1016/j.jcjo.2012.12.002. PubMed PMID: 23561607.
`
`80. Gonzalez MA, Flynn HW Jr., Smiddy WE, Albini TA, Berrocal AM, et al. Giant
`retinal tears after prior pars plana vitrectomy: Management Strategies and
`Outcomes. Clin Ophthalmol. 2013;7:1687-9